课题基金 / 基金详情

OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS

OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
阿齐利特治疗室上性心律失常的开放标签试验
批准号:
6415265
负责人:
EDWARD L PRITCHETT
金额:
$29.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2001-11-30

项目摘要

项目成果

EDWARD L PRITCHETT的其他基金

相似基金

相关文献

中文摘要
翻译
杜克大学医学中心临床药理学和心脏病学部门的研究人员利用兰金临床研究单位研究心房颤动和其他常见心律紊乱患者。房颤是最常见的心律紊乱,需要抗心律失常药物治疗,在美国因心律失常住院的患者中,房颤占三分之一以上。心房颤动患者通常正常的心律被快速、不规则的心脏跳动所取代,这可能导致胸部搏击感、呼吸短促、胸痛、头晕或意识丧失。这些症状可能持续几分钟或几小时,也可能无限期持续,除非医生给予紧急治疗。Azimilide是一种重要的III类抗心律失常药物,可阻断快速和慢速向内钾通道。目前正在开发一种治疗方法,以减少心房颤动、心房扑动或两者兼有的患者出现症状性心律失常的频率。在方案D88例房颤患者成功地完成了阿齐米利的随机、安慰剂对照临床试验,每日给予开放标签阿齐米利75毫克或100毫克治疗。随访已完成,在本方案中没有进一步的患者随访。
英文摘要
Investigators in the Divisions of Clinical Pharmacology and Cardiology at Duke University Medical Center have used the Rankin Clinical Research Unit to study patients with atrial fibrillation and other common disorders of the heart rhythm. Atrial fibrillation is the most common disorder of the heart rhythm requiring treatment with antiarrhythmic drugs, and it accounts for over one-third of all U.S. hospitalizations for arrhythmias. Patients with atrial fibrillation have their usually normal heart rhythm replaced by periods of rapid, irregular heart beating that may cause a sense of pounding in the chest, shortness of breath, chest pain, dizziness, or loss of consciousness. These periods may last for minutes or hours, or they may last indefinitely unless acute treatment is given by a physician. Azimilide is an important investigational class III antiarrhythmic drug that blocks both rapid and slow inward potassium channels. It is being developed as a therapy to reduce the frequency of symptomatic arrhythmia occurrences in patients with atrial fibrillation, atrial flutter or both. In protocol D88 patients with atrial fibrillation who had successfully completed a randomized, placebo-controlled clinical trial of azimilide were treated with open-label azimilide75 mg or 100 mg daily. Follow-up has been completed, and no further patients are being followed in this protocol.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
  • 批准号:
    6565344
  • 项目类别:
  • 资助金额:
    $11.7万
  • 财政年份:
    2001
  • 负责人:
    EDWARD L PRITCHETT
  • 依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
  • 批准号:
    6565362
  • 项目类别:
  • 资助金额:
    $11.7万
  • 财政年份:
    2001
  • 负责人:
    EDWARD L PRITCHETT
  • 依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
  • 批准号:
    6565324
  • 项目类别:
  • 资助金额:
    $11.7万
  • 财政年份:
    2001
  • 负责人:
    EDWARD L PRITCHETT
  • 依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
  • 批准号:
    6463047
  • 项目类别:
  • 资助金额:
    $11.7万
  • 财政年份:
    2000
  • 负责人:
    EDWARD L PRITCHETT
  • 依托单位:
海外基金